We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Oncimmune Holdings Plc | LSE:ONC | London | Ordinary Share | GB00BYQ94H38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
2.70 | 10.23% | 29.10 | 27.20 | 31.00 | 30.20 | 27.00 | 27.00 | 215,861 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 1.47M | -6.15M | -0.0830 | -3.61 | 22.24M |
TIDMONC
RNS Number : 9290A
Oncimmune Holdings PLC
29 March 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ----------------------------------------------------------------------------------------------- 1. Identity of the issuer or Oncimmune Holdings PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- -------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------- ------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------- ------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------- ------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------- ------------------------------- Other (please specify): ------------------------------------------------------------ ------------------------------- 3. Full name of person(s) Professor John Forsyth Russell subject to the Robertson notification obligation: (iii) ------------------------------------------------------------- -------------------------------- 4. Full name of shareholder(s) As above (if different from 3.):(iv) ------------------------------------------------------------- -------------------------------- 5. Date of the transaction 24 March 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- -------------------------------- 6. Date on which issuer 24 March 2017 notified: ------------------------------------------------------------- -------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 6%, 5% ------------------------------------------------------------- -------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ----------- ---------------------------------- --------------------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights ----------- ---------------- ---------------- -------------- -------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ----------- ------------ ------------ -------------- ------------ ------------ ------------ ----------- Ordinary Shares 3,123,253 3,123,253 2,103,253 2,103,253 1,020,000 4.12% 2.00% ---------------- ---------------- -------------- ------------ ------------ ------------ ----------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. --------------- -------------- -------------------------------- ---------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) ------------- -------------- -------------- ---------------- ---------------------------- ----------------------- Nominal Delta ------------- -------------- -------------- ---------------- ---------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 3,123,253 6.12% ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ------------------------------------------------------------------------------------------------- 1,020,000 voting rights are held in discretionary family trusts of which the shareholder is a trustee. Proxy Voting: ------------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ---------------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ---------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ---------------------------------- 644,550 shares are jointly 13. Additional information: held with the Oncimmune Employee Benefit Trust. ------------------------------------------------------------- ---------------------------------- 14. Contact name: Mark Cooper, BHP, Chartered Accountants ------------------------------------------------------------- ---------------------------------- 15. Contact telephone number: 0114 266 7171 ------------------------------------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUKOSRBUAOUAR
(END) Dow Jones Newswires
March 29, 2017 10:35 ET (14:35 GMT)
1 Year Oncimmune Chart |
1 Month Oncimmune Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions